Basit öğe kaydını göster

dc.contributor.authorEroğul, Özgür
dc.contributor.authorGobeka, Hamidu Hamisi
dc.contributor.authorKaşıkçı, Murat
dc.contributor.authorEryiğit Eroğul, Leyla
dc.contributor.authorBalcı, Aydın
dc.date.accessioned2022-06-20T13:18:51Z
dc.date.available2022-06-20T13:18:51Z
dc.date.issued2022en_US
dc.identifier.citationErogul, O., Gobeka, H.H., Kasikci, M. et al. Impacts of protective face masks on ocular surface symptoms among healthcare professionals during the COVID-19 pandemic. Ir J Med Sci (2022). https://doi.org/10.1007/s11845-022-03059-xen_US
dc.identifier.urihttps://doi.org/10.1007/s11845-022-03059-x
dc.identifier.urihttps://hdl.handle.net/20.500.12809/10045
dc.description.abstractBackground: To assess the impacts of prolonged protective face masks (PFM) wear on ocular surface symptoms among healthcare professionals (HCPs), and how these symptoms affected PFM wear. Methods: Thirty-question survey forms were distributed via social media platform to 396 HCPs (110 doctors, 164 nurses, and 122 health technicians) between September 8 and 30, 2021. Participants who could not be reached via social media were given a face-to-face questionnaire. Aside from sociodemographic data, the questionnaire inquired about PFM wear, PFM types, ocular surface symptoms, and how PFM wear has changed during the COVID-19 pandemic. Results: A total of 74.5% of HCPs reported wearing PFMs, mostly surgical ones (76.8%), for half a day at work but not at home, with redness (29.3%) being the most frequently encountered ocular surface symptom, followed by burning (15.7%), pain (14.1%), tingling (10.9%), and rash (6.6%). The presence of associated restrictions in conjunction with PFM-related ocular symptoms was more likely in dry and hot environments. There was no significant relationship between PFM type, PFM-wearing duration, and HCPs' daily activities (p > 0.05). Despite the lack of a significant relationship between PFM types and ocular surface symptoms (p > 0.05), there was a significant relationship between PFM-wearing duration and ocular pain (p < 0.05). Conclusions: PFM-related ocular surface symptoms can be alleviated by properly wearing PFMs, reducing wear time, and using long-acting topical lubricants. This could improve PFM wear compliance, prevent disease transmission, and ultimately help with COVID-19 protection.en_US
dc.item-language.isoengen_US
dc.publisherSpringerlinken_US
dc.relation.isversionof10.1007/s11845-022-03059-xen_US
dc.item-rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCOVID -19en_US
dc.subjectHealthcare professionalsen_US
dc.subjectOcular symptomsen_US
dc.subjectProtective face masksen_US
dc.subjectQuestionnaireen_US
dc.titleImpacts of protective face masks on ocular surface symptoms among healthcare professionals during the COVID-19 pandemicen_US
dc.item-typearticleen_US
dc.contributor.departmentMÜ, Tıp Fakültesi, Eğitim ve Araştırma Hastanesiüen_US
dc.contributor.authorID0000-0002-7656-3155en_US
dc.contributor.authorID0000-0002-2748-9702en_US
dc.contributor.institutionauthorGobeka, Hamidu Hamisi
dc.contributor.institutionauthorKaşıkçı, Murat
dc.relation.journalIrish Journal of Medical Science (1971 -)en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster